Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to estimate the maximum tolerated dose of irinotecan
with the use of cefpodoxime for pediatric solid tumor patients.